Some musculo-skeletal sequelae in cancer survivors

Acta Oncologica

Volumn 46, Issue 4, 2007, Pages 490-496

  Aksnes, Liv Hege ^a   Bruland, Øyvind Sverre ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LETROZOLE; VITAMIN D; ZOLEDRONIC ACID;

ARTICLE; BONE ATROPHY; CALCIUM DEFICIENCY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIET THERAPY; HUMAN; HYPOGONADISM; LIFESTYLE MODIFICATION; MUSCULOSKELETAL DISEASE; MYALGIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SARCOMA; SITTING; SURVIVOR; VITAMIN D DEFICIENCY;

AMPUTEES; BONE RESORPTION; CALCIUM; DRUG THERAPY; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOMOTOR DISORDERS; QUALITY OF LIFE; RADIOTHERAPY; SURVIVORS; VITAMIN D DEFICIENCY;

EID: 34248594285     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701218642     Document Type: Article

References (68)

1. Polomano RC, Farrar JT. Pain and neuropathy in cancer survivors: Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs 2006;106(Suppl 3):39-47.
2. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49.
3. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2006;249:9-17.
4. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 2004;12:619-25.
5. Bae DC, Stein BS. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol 2004;172:2137-44.
6. Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 1. Am J Health-Syst Pharm 2006;63:419-30.
7. Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Osteoporosis in children and adolescents: Etiology and management. Paediatr Drugs 2005;7:295-323.
8. Hoff AO, Gagel RF. Osteoporosis in breast and prostate cancer survivors. Oncology 2005;19:651-8.
9. WHO scientific group. Prevention and Management of Osteoporosis. 2003.
10. Chien AJ, Goss PE. Aromatase inhibitors and bone health in women with breast cancer. J Clin Oncol 2006;24:5305-12.
11. Kaste SC, Chesney RW, Hudson MM, Lustig RH, Rose SR, Carbone LD. Bone mineral status during and after therapy of childhood cancer: An increasing population with multiple risk factors for impaired bone health. J Bone Mineral Res 1999;14:2010-2.
12. Fontanges E, Fontana A, Delmas P. Osteoporosis and breast cancer. Joint Bone Spine 2004;71:102-10.
13. Hawkins R. Osteoporosis. Am J Nurs 2006;106(Suppl 3):78-82.
14. Holmes-Walker DJ, Woo H, Gurney H, Do VT, Chipps DR. Maintaining bone health in patients with prostate cancer. Med J Aust 2006;184:176-9.
15. Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: Pathogenesis and management. J Clin Oncol 2000;18:1570-93.
16. Smith MR. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer Supplement 2003;97:789-95.
17. Mandel K, Atkinson S, Barr RD, Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004;22:1215-20.
18. Holzer G, Krepler P, Koschat MA, Grampp S, Dominkus M, Kotz R. Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg (Br) 2003;85-B:231-7.
19. Kaste SC. Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods. Pediatr Radiol 2004;34:373-8.
20. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ, Jaffe N. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol 1999;32:272-8.
21. Haddy TB, Mosher RB, Reaman GH. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist 2001;6:278-85.
22. Othman F, Guo CY, Webber C, Atkinson SA, Barr RD. Osteopenia in survivors of Wilm's tumor. Int J Oncol 2002;20:827-33.
23. Barr RD, Simpson T, Webber CE, Gill GJ, Hay J, Eves M, et al. Osteopenia in children surviving brain tumours. Eur J Cancer 1998;34:873-7.
24. Odame I, Duckworth J, Talsma D, Beaumont L, Furlong W, Webber C, et al. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer 2006;46:357-62.
25. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Eng J Med 1992;326:852-6.
26. Resch A, Biber E, Seifert M, Resch H. Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer. Acta Oncol 1998;37:661-4.
27. Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, et al. American Society of Clinical Oncology: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042-57.
28. Eastell R, Hannon R. Long-term effects of aromatase inhibitors on bone. J Steroid Biochem Mol Biol 2005;95:151-4.
29. van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 2000;26:363-76.
30. Theriault RL. Pathophysiology and implications of cancer treatment-induced bone loss. Oncology 2004;18(5 Suppl 3):11-5.
31. Bianchi ML. Glucorticoids and bone: Some general remarks and some special observations in pediatric patients. Calcif Tissue Int 2002;70:384-90.
32. Conde FA, Aronson WJ. Risk factors for male osteoporosis. Urol Oncol: Sem Orig Invest 2003;21:380-3.
33. Smith MR. Treatment-related osteoporosis in men with prostate cancer. Clin Cancer Res 2006;12:6315-9.
34. Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies. Cancer 2004;100:892-9.
35. Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 2. Am J Health-Syst Pharm 2006;63:534-46.
36. Brufsky A. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: A Z-FAST update. Semin Oncol 2006;33(Suppl 7):s13-s17.
37. Butler MS, Robertson WW Jr, Rate W, D'Angio GJ, Drummond DS. Skeletal sequelae of radiation therapy for malignant childhood tumors. Clin Orthop 1990;251:235-40.
38. Fletcher BD. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol 1997;27:623-36.
39. Parisi MT, Fahmy JL, Kaminsky CK, Malogolowkin MH. Complications of cancer therapy in children: A radiologist's guide. Radiographics 1999;19:283-96.
40. Ballo MT, Zagars GK. Radiation therapy for soft tissue sarcoma. Surg Oncol Clin North Am 2003;12:449-67.
41. DeLaney TF, Thomas F. Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma. Curr Treat Options Oncol 2004;5:463-76.
42. O'Sullivan B, Ward I, Catton C. Recent advances in radio-therapy for soft-tissue sarcoma. Curr Oncol Rep 2003;5:274-81.
43. Strander H, Turesson I, Cavallin-Stahl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 2003;42:516-31.
44. Riseborough EJ, Grabias SL, Burton RI, Jaffe N. Skeletal alterations following irradiation for Wilms' tumor: With particular reference to scoliosis and kyphosis. J Bone Joint Surg (Am) 1976;58:526-36.
45. Paulino AC, Wen BC, Brown CK, Tannous R, Mayr NA, Zhen WK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2004;60:265-74.
46. Paulino AC, Fowler BZ. Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys 2005;61:865-9.
47. Lyne ME, Coyne PJ, Watson AC. Pain management issues for cancer survivors. Cancer Practice 2002;10(Suppl 1):s27-s32.
48. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 2003;290:1583-92.
49. Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 1995;31:1309-18.
50. Keating NL, Norredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older longterm cancer survivors. J Am Geriatr Soc 2005;53:2145-52.
51. Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, et al. Management of high-grade bone sarcomas over two decades: The Norwegian Radium Hospital experience. Acta Oncol 2006;45:38-46.
52. Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: An updated report. J Clin Oncol 2000;18:4016-27.
53. Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol 2005;6:85-92.
54. Veth R, van HR, Pruszczynski M, Hoogenhout J, Schreuder B, Wobbes T. Limb salvage in musculoskeletal oncology. Lancet Oncol 2003;4:343-50.
55. Nagarajan R, Neglia JP, Clohisy DR, Robison LL. Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: What are the long-term implications? J Clin Oncol 2002;20:4493-501.
56. Wilkins RM, Miller CM. Reoperation after limb preservation surgery for sarcomas of the knee in children. Clinical Orthop 2003;412:153-61.
57. Eiser C, Darlington A-SE, Stride CB, Grimer RJ. Quality of life implication as a consequence of surgery: Limb salvage, primary and secondary amputation. Sarcoma 2001;5:189-95.
58. Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS. Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: A matched case-control study. Arch Phys Med Rehabil 1999;80:615-8.
59. Grimer RJ, Taminiau AM, Cannon SR. Surgical outcomes in osteosarcoma. J Bone Joint Surg (Br) 2002;84-B:395-400.
60. Hopyan SMPF, Tan JWM, Graham HKM, Torode IPF. Function and upright time following limb salvage, amputation, and rotationplasty for pediatric sarcoma of bone. J Pediatr Orthopaed 2006;26:405-8.
61. Nagarajan R, Clohisy DR, Neglia JP, Yasui Y, Mitby PA, Sklar C, et al. Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: The Childhood Cancer Survivor Study. Br J Cancer 2004;91:1858-65.
62. Postma A, Kingma A, De Ruiter JH, Schraffordt KH, Veth RP, Goeken LN, et al. Quality of life in bone tumor patients comparing limb salvage and amputation of the lower extremity. J Surg Oncol 1992;51:47-51.
63. Refaat YM, Gunnoe JB, Hornicek FJM, Mankin HJM. Comparison of quality of life after amputation or limb salvage. Clinical Orthop 2002;397:298-305.
64. Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van H Jr. Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 2000;73:198-205.
65. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 1994;76:649-56.
66. Zahlten-Hinguranage A, Bernd L, Ewerbeck V, Sabo D. Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas. Br J Cancer 2004;91:1012-4.
67. Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41:229-37.
68. Sprangers MA, Van Dam FS, Broersen J, Lodder L, Wever L, Visser MR, et al. Revealing response shift in longitudinal research on fatigue-the use of the thentest approach. Acta Oncol 1999;38:709-18.